tiprankstipranks
International Stem Cell (DE:0IS1)
BERLIN:0IS1
TipRanksstock market overviewInternational Stem Cell Stock Analysis & Ratings

International Stem Cell Stock Analysis & Ratings

0 Followers

0IS1 Stock Chart & Stats

Day’s Range€0 - €0
52-Week Range€0.28 - €0.62
Previous Close€0.3
Volume0.00
Average Volume (3M)N/A
Market CapN/A
Enterprise ValueN/A
P/E RatioN/A
Beta-0.29
Next EarningsApr 11, 2023
EPS ForecastN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price TargetN/A
Smart ScoreN/A
EPS (TTM)N/A
Shares Outstanding8,004,389
R-Squared0.15
Standard Deviation17.36
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
P/B Ratio-0.55
P/S Ratio2.31
P/CF RatioN/A
P/FCF Ratio-5.00
Total Debt€1.13M
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/EbitdaN/A
Price Target UpsideN/A
Rating ConsensusN/A
Alpha3.89
Number of Analyst Covering0


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

0IS1 FAQ

What was International Stem Cell’s price range in the past 12 months?
International Stem Cell lowest stock price was €0.28 and its highest was €0.62 in the past 12 months.
    What is International Stem Cell’s market cap?
    Currently, no data Available
    What is International Stem Cell’s price target?
    Currently, no data Available
    What do analysts say about International Stem Cell?
    Not enough analysts have published a price target to provide an average price target.
    When is International Stem Cell’s upcoming earnings report date?
    International Stem Cell’s upcoming earnings report date is Apr 11, 2023 which is in 240 days.
      How were International Stem Cell’s earnings last quarter?
      International Stem Cell released its earnings results on May 17, 2022. The company reported >-€0.001 earnings per share for the quarter, missing the consensus estimate of N/A by >-€0.001.
        Is International Stem Cell overvalued?
        According to Wall Street analysts International Stem Cell’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does International Stem Cell pay dividends?
          International Stem Cell does not currently pay dividends.
          What is International Stem Cell’s EPS estimate?
          International Stem Cell’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does International Stem Cell have?
          Currently, no data Available
          What happened to International Stem Cell’s price movement after its last earnings report?
          International Stem Cell reported an EPS of >-€0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.83%.
            Which hedge fund is a major shareholder of International Stem Cell?
            Currently, no hedge funds are holding shares in DE:0IS1

            ---

            International Stem Cell Stock Analysis

            Smart ScoreNot Ranked
            1
            2
            3
            4
            5
            6
            7
            8
            9
            10
            N/A

            Analyst Forecast

            N/A
            Currently Not Enough Data Available

            Blogger Sentiment

            N/A
            Currently Not Enough Data Available

            Insider Transactions

            N/A
            Currently Not Enough Data Available

            News Sentiment

            N/A
            Currently Not Enough Data Available

            Technicals

            SMA
            Negative
            20 days / 200 days
            Momentum
            -43.63%
            12-Months-Change

            Fundamentals

            Return on Equity
            N/A
            Trailing 12-Months
            Asset Growth
            -3.48%
            Trailing 12-Months
            This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
            Learn more about TipRanks Smart Score

            Company Description

            International Stem Cell

            International Stem Cell Corp. is a clinical stage biotechnology company, which engages in the development of therapeutic and biomedical products. It operates through the following segments: Cosmetic Market, Biomedical Market, and Therapeutic Market. The Cosmetic Market segment develops, manufactures, and markets a cosmetic skin care products based on the company's proprietary parthenogenetic stem cell technology and targeted small molecule technology. The Biomedical Market segment involves in the development, manufacture, and commercialization of primary human cell research products. The Therapeutic Market segment focuses on the research and development of human parthenogenetic stem cells for the treatment of diseases of the central nervous system, liver diseases, and is currently conducting clinical trials for the treatment of Parkinson's disease. The company was founded by William B. Adams, Kenneth C. Aldrich, and Gregory S. Keller on August 17, 2001 and is headquartered in Carlsbad, CA.

            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            AbbVie
            Amgen
            Gilead Sciences
            Moderna
            Vertex Pharmaceuticals

            Popular Stocks

            ---
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis